Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):
-Net Income: $1.23 Bln in Q2 vs. $1.07 Bln in the same period last year.
-EPS: $1.43 in Q2 vs. $1.25 in the same period last year.
-Revenue: $4.97 Bln in Q2 vs. $5.05 Bln in the same period last year.
-Guidance:
Full year EPS guidance: $5.15 - $5.40
Full year revenue guidance: $19.0 - $19.4 Bln
For comments and feedback contact: editorial@rttnews.com